First, the market momentum for Mirum's rare liver disease drug Livmarli should continue. Sales increased 56% year-over-year ...
The third no-brainer stock that can be confidently bought with $1,000 right now for the new year is America's largest ...
These funds are highly rated. Here's what they offer Aussie investors. The post Where I would invest $5,000 in ASX ETFs in ...
These five are great starting points for nearly surefire bets for 2026.
Are you looking for some dividend-growth stocks to add to your portfolio? Here are two great picks that every investor should consider owning. The post 2 Dividend-Growth Stocks to Buy and Hold Through ...
This TSX stock has a steady dividend payment history, offers monthly distributions, and has a high and sustainable yield. The ...
Still, much of the market, including Wall Street analysts, sees room to run in the AI sector. Here's one AI company to buy ...
Federal Housing Finance Director Bill Pulte said government-controlled enterprises Fannie Mae (Federal National Mortgage ...
A strong performance during a single year may not be indicative of whether a company can perform well over a decade, but ...
In retrospect, Alphabet and Nvidia were the top Magnificent Seven stocks for investors to buy at the beginning of 2025. What ...
Among the 100 predominantly growth-driven companies that comprise the Nasdaq-100, you'll find two phenomenal businesses with ...
Not sure where to begin? These funds could be a good starting point. The post New to Investing? Here are 3 ASX ETFs to get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback